17. Effects of Cariprazine on Negative Symptoms, Cognitive Impairment, and Prosocial Functioning in Patients With Predominant Negative Symptoms: Post Hoc Analysis of a Phase III, Placebo-, and Active-Controlled Study

Lignende værker

• The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis
  af: Nasrallah, Henry A., et al.
  Udgivet: (2017)
• Global improvement with cariprazine in the treatment of bipolar I disorder and schizophrenia: A pooled post hoc analysis
  af: Durgam, Suresh, et al.
  Udgivet: (2017)
• Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trial
  af: Fava, Maurizio, et al.
  Udgivet: (2018)
• SU14. Characteristics Associated With Relapse in Patients With Schizophrenia: Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Cariprazine Relapse Prevention Trial
  af: Kunovac, Jelena, et al.
  Udgivet: (2017)
• Linking PANSS negative symptom scores with the Clinical Global Impressions Scale: understanding negative symptom scores in schizophrenia
  af: Leucht, Stefan, et al.
  Udgivet: (2019)